Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1514926
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1514926
Therapeutic Proteins and Oral Vaccines Market, By Therapeutic Protein Type, By Delivery Method, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
PUBLISHED:
PAGES: 393 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Therapeutic Proteins and Oral Vaccines Market size was valued at USD 251.45 Million in 2023, expanding at a CAGR of 7.9% from 2024 to 2032.
The Therapeutic Proteins and Oral Vaccines market encompasses treatments utilizing proteins and convenient oral vaccines. This growth is fueled by the rising need for these therapies, particularly in cancer, diabetes, and infectious diseases. Increased clinical trials, advancements in protein engineering, and growing government support for research are propelling the market forward. However, high manufacturing costs and stringent regulatory hurdles pose challenges. Despite these, the potential for personalized medicine using therapeutic proteins and the growing demand for needle-free vaccination present exciting market opportunities.
Therapeutic Proteins and Oral Vaccines Market- Market Dynamics
Personalized Medicine & Easy Prevention Drive Therapeutic Protein & Oral Vaccine Market Growth
Personalized medicine and easy prevention strategies using therapeutic proteins and oral vaccines are fueling a boom in the healthcare market. American Cancer Society data shows CAR-T cell therapy, a personalized protein treatment, achieving an 80% remission rate in some leukemias. Furthermore, a 2023 World Health Organization report suggests oral vaccines could raise childhood immunization rates in developing countries by 20% due to their user-friendliness. This confluence of personalized treatments and convenient preventative methods is driving substantial investment and propelling market growth within the Therapeutic Protein and Oral Vaccine sectors.
Therapeutic Proteins and Oral Vaccines Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.9% over the forecast period (2024-2032)
Based on Therapeutic Protein Type segmentation, Monoclonal Antibodies were predicted to show maximum market share in the year 2023
Based on Delivery Method segmentation, Injections were the leading type in 2023
Based on region, North America was the leading revenue generator in 2023
Therapeutic Proteins and Oral Vaccines Market- Segmentation Analysis:
The Global Therapeutic Proteins and Oral Vaccines Market is segmented based on Therapeutic Protein Type, Delivery Method, Application, and Region.
The market is divided into six categories based on Therapeutic Protein Type: Monoclonal Antibodies, Enzymes, Growth Factors, Interferons, Interleukins, and Vaccines. Monoclonal antibodies dominate the therapeutic protein segment due to their targeted approach to treating various cancers and autoimmune diseases. Enzymes are gaining traction for metabolic disorders, while growth factors hold promise in tissue regeneration. Interferons and interleukins show potential in immunomodulation, and vaccines, especially oral ones, are revolutionizing preventative care.
The market is divided into three categories based on Delivery Method: Injection, Inhalation, and Topical application. Injections remain the dominant delivery method for therapeutic proteins due to precise dosage control and effectiveness. Inhalation is gaining traction for respiratory diseases, while topical applications offer convenience for localized treatment.
Therapeutic Proteins and Oral Vaccines Market- Geographical Insights
North America holds the highest share due to factors like high healthcare expenditure, rising chronic disease prevalence, and established research infrastructure. However, regions like Asia Pacific are experiencing rapid growth fueled by increasing disposable income, government healthcare initiatives, and a large patient population. Europe, with its strong focus on biopharmaceutical development, presents a mature market with steady growth. Developing countries in Africa and Latin America offer significant potential due to unmet medical needs and growing government investments in healthcare. The success of companies in this market will depend on their ability to navigate regional regulations, develop pricing strategies that cater to varying economic landscapes, and establish partnerships to ensure wider accessibility.
Therapeutic Proteins and Oral Vaccines Market- Competitive Landscape:
The Therapeutic Proteins and Oral Vaccines market is a competitive arena with established pharmaceutical giants like Amgen, Pfizer, and Johnson & Johnson vying for dominance. These players leverage their extensive R&D budgets to develop innovative therapies and oral vaccines. Mergers and acquisitions are another strategic move, for instance, Pfizer's acquisition of a leading sickle cell therapy company. Additionally, smaller biotechnology firms are emerging with promising niche solutions, fostering a dynamic environment. Collaboration between these players, with academic institutions and government agencies, is crucial for accelerating research and development. The competitive landscape is further intensified by the growing focus on biosimilars, which offer cost-effective alternatives to established protein therapies. This not only puts pressure on pricing but also compels companies to constantly innovate and differentiate their products.
Recent Developments:
In January 2022, Amgen Inc., a biotechnology company, and Generate Biomedicines, a drug generation company, announced a research collaboration agreement to discover and create protein therapeutics for five clinical targets across various disease areas.
In November 2022, Merck & Co., Inc. announced that it would acquire Imago BioSciences, Inc., a clinical-stage biopharmaceutical company developing new medicines for the treatment of myeloproliferative neoplasms, for approximately USD 1.35 billion. Imago's lead candidate, bomedemstat, is an investigational orally available lysine-specific demethylase 1 (LSD1) inhibitor currently being evaluated in multiple Phase 2 clinical trials.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Abbott Laboratories
Amgen Inc.
Biogen Inc.
Eli Lilly and Company
Emergent Biosolutions Inc.
F. Hoffmann-La Roche Ltd
Johnson & Johnson
Lumen Bioscience Inc.
Merck & Co., Inc.
MigVax Ltd
Neurelis Inc.
Novo Nordisk A/S
Pfizer Inc.
Sanofi S.A.
Serum Institute of India Pvt. Ltd.
TransAlgae
Others
GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY THERAPEUTIC PROTEIN TYPE- MARKET ANALYSIS, 2019 - 2032
- Monoclonal Antibodies
- Enzymes
- Growth Factors
- Interferons
- Interleukins
- Vaccines
GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032
- Injection
- Inhalation
- Topical application
GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Cancer
- Autoimmune Diseases
- Infectious Diseases
- Neurological Disorders
- Metabolic Disorders
- Other Diseases
GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV2997
Table of Contents
1. Therapeutic Proteins and Oral Vaccines Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Therapeutic Proteins and Oral Vaccines Market Snippet by Therapeutic Protein Type
- 2.1.2. Therapeutic Proteins and Oral Vaccines Market Snippet by Delivery Method
- 2.1.3. Therapeutic Proteins and Oral Vaccines Market Snippet by Application
- 2.1.4. Therapeutic Proteins and Oral Vaccines Market Snippet by Country
- 2.1.5. Therapeutic Proteins and Oral Vaccines Market Snippet by Region
- 2.2. Competitive Insights
3. Therapeutic Proteins and Oral Vaccines Key Market Trends
- 3.1. Therapeutic Proteins and Oral Vaccines Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Therapeutic Proteins and Oral Vaccines Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Therapeutic Proteins and Oral Vaccines Market Opportunities
- 3.4. Therapeutic Proteins and Oral Vaccines Market Future Trends
4. Therapeutic Proteins and Oral Vaccines Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Therapeutic Proteins and Oral Vaccines Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Therapeutic Proteins and Oral Vaccines Market Landscape
- 6.1. Therapeutic Proteins and Oral Vaccines Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Therapeutic Proteins and Oral Vaccines Market - By Therapeutic Protein Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Therapeutic Protein Type, 2023 & 2032 (%)
- 7.1.2. Monoclonal Antibodies
- 7.1.3. Enzymes
- 7.1.4. Growth Factors
- 7.1.5. Interferons
- 7.1.6. Interleukins
- 7.1.7. Vaccines
8. Therapeutic Proteins and Oral Vaccines Market - By Delivery Method
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Delivery Method, 2023 & 2032 (%)
- 8.1.2. Injection
- 8.1.3. Inhalation
- 8.1.4. Topical application
9. Therapeutic Proteins and Oral Vaccines Market - By Application
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 9.1.2. Cancer
- 9.1.3. Autoimmune Diseases
- 9.1.4. Infectious Diseases
- 9.1.5. Neurological Disorders
- 9.1.6. Metabolic Disorders
- 9.1.7. Other Diseases
10. Therapeutic Proteins and Oral Vaccines Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Therapeutic Proteins and Oral Vaccines Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Abbott Laboratories
- 11.2.2. Amgen Inc.
- 11.2.3. Biogen Inc.
- 11.2.4. Eli Lilly and Company
- 11.2.5. Emergent Biosolutions Inc.
- 11.2.6. F. Hoffmann-La Roche Ltd
- 11.2.7. Johnson & Johnson
- 11.2.8. Lumen Bioscience Inc.
- 11.2.9. Merck & Co., Inc.
- 11.2.10. MigVax Ltd
- 11.2.11. Neurelis Inc.
- 11.2.12. Novo Nordisk A/S
- 11.2.13. Pfizer Inc.
- 11.2.14. Sanofi S.A.
- 11.2.15. Serum Institute of India Pvt. Ltd.
- 11.2.16. TransAlgae
- 11.2.17. Others
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
Product Code: ANV2997
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Therapeutic Proteins and Oral Vaccines Market: Therapeutic Protein Type Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Therapeutic Protein Type
- TABLE Global Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type 2019-2032 (USD Million)
- TABLE Therapeutic Proteins and Oral Vaccines Market: Delivery Method Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Delivery Method
- TABLE Global Therapeutic Proteins and Oral Vaccines Market, by Delivery Method 2019-2032 (USD Million)
- TABLE Therapeutic Proteins and Oral Vaccines Market: Application Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Application
- TABLE Global Therapeutic Proteins and Oral Vaccines Market, by Application 2019-2032 (USD Million)
- TABLE Therapeutic Proteins and Oral Vaccines Market: Regional snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Therapeutic Proteins and Oral Vaccines Market, by Region 2019-2032 (USD Million)
- TABLE North America Therapeutic Proteins and Oral Vaccines Market, by Country, 2019-2032 (USD Million)
- TABLE North America Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type, 2019-2032 (USD Million)
- TABLE North America Therapeutic Proteins and Oral Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
- TABLE North America Therapeutic Proteins and Oral Vaccines Market, by Application, 2019-2032 (USD Million)
- TABLE Europe Therapeutic Proteins and Oral Vaccines Market, by Country, 2019-2032 (USD Million)
- TABLE Europe Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type, 2019-2032 (USD Million)
- TABLE Europe Therapeutic Proteins and Oral Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
- TABLE Europe Therapeutic Proteins and Oral Vaccines Market, by Application, 2019-2032 (USD Million)
- TABLE Asia Pacific Therapeutic Proteins and Oral Vaccines Market, by Country, 2019-2032 (USD Million)
- TABLE Asia Pacific Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type, 2019-2032 (USD Million)
- TABLE Asia Pacific Therapeutic Proteins and Oral Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
- TABLE Asia Pacific Therapeutic Proteins and Oral Vaccines Market, by Application, 2019-2032 (USD Million)
- TABLE Latin America Therapeutic Proteins and Oral Vaccines Market, by Country, 2019-2032 (USD Million)
- TABLE Latin America Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type, 2019-2032 (USD Million)
- TABLE Latin America Therapeutic Proteins and Oral Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
- TABLE Latin America Therapeutic Proteins and Oral Vaccines Market, by Application, 2019-2032 (USD Million)
- TABLE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market, by Country, 2019-2032 (USD Million)
- TABLE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type, 2019-2032 (USD Million)
- TABLE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
- TABLE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market, by Application, 2019-2032 (USD Million)
List of Figures
- FIGURE Therapeutic Proteins and Oral Vaccines Market Segmentation
- FIGURE Market research methodology
- FIGURE Value chain analysis
- FIGURE Porter's Five Forces Analysis
- FIGURE Market Attractiveness Analysis
- FIGURE COVID-19 Impact Analysis
- FIGURE Pre & Post COVID-19 Impact Comparision Study
- FIGURE Competitive Landscape; Key company market share analysis, 2023
- FIGURE Therapeutic Protein Type segment market share analysis, 2023 & 2032
- FIGURE Therapeutic Protein Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Delivery Method segment market share analysis, 2023 & 2032
- FIGURE Delivery Method segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Application segment market share analysis, 2023 & 2032
- FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Regional segment market share analysis, 2023 & 2032
- FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE North America Therapeutic Proteins and Oral Vaccines Market share and leading players, 2023
- FIGURE Europe Therapeutic Proteins and Oral Vaccines Market share and leading players, 2023
- FIGURE Asia Pacific Therapeutic Proteins and Oral Vaccines Market share and leading players, 2023
- FIGURE Latin America Therapeutic Proteins and Oral Vaccines Market share and leading players, 2023
- FIGURE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market share and leading players, 2023
- FIGURE North America market share analysis by country, 2023
- FIGURE U.S. Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Canada Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Europe Therapeutic Proteins and Oral Vaccines Market share analysis by country, 2023
- FIGURE Germany Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Spain Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Italy Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE France Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE UK Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Russia Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Netherlands Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Sweden Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Poland Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of the Europe Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Asia Pacific Therapeutic Proteins and Oral Vaccines Market share analysis by country, 2023
- FIGURE India Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE China Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Japan Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE South Korea Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Australia Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Thailand Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Indonesia Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Philippines Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of APAC Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Latin America Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Latin America Therapeutic Proteins and Oral Vaccines Market share analysis by country, 2023
- FIGURE Brazil Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Mexico Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Argentina Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Colombia Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of LATAM Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market share analysis by country, 2023
- FIGURE Saudi Arabia Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE United Arab Emirates Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Israel Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Turkey Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Algeria Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Egypt Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of MEA Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.